香港股市 已收市

微創機器人-B (2252.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
11.820-0.340 (-2.80%)
收市:04:08PM HKT

微創機器人-B

Building 1
Room 101, Area B 1601 Zhangdong Road China (Shanghai) Pilot Free Trade Zone
Shanghai
China
86 21 3895 4600
https://www.medbotsurgical.com

版塊Healthcare
行業Medical Devices
全職員工646

高階主管

名稱頭銜支付行使價出生年份
Dr. Chao HePresident & Executive Director2.7M1986
Ms. Xiaoyu CuiFinancial Controller1980
Mr. Yu LiuExecutive VP & Chief Commercial Officer1970
Ms. Cong FangBoard Secretary1990
Ms. Yin Shan Hui A.C.I.S., A.C.S., HKICS, ICSACompany Secretary1969
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots for spine surgery; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and thoracic and abdominal puncture surgical robot for percutaneous lung biopsy and percutaneous liver biopsy. In addition, it manufactures parts of surgical robot devices; engages in assembly and distribution of surgical robot devices; research and development of system, as well as investment activities. Shanghai MicroPort MedBot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.

公司管治

截至 無 止,微創機器人-B 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。